CreditReports.dk
HomeScreen companies

Pharma Equity Group A/S Financials, key figures and credit report

CVR number: 26791413 Established 2002 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Slotsmarken 12, 2970 Hørsholm info@pharmaequitygroup.com tel: 32548800 www.pharmaequitygroup.com
Gross profit — FY 2016
EBIT -1 320.0 kDKK FY 2016 +51.3% vs 2015
Net debt 556.0 kDKK FY 2016 +247.9% vs 2015
Quick ratio 1.0 FY 2016 +0.2 vs 2015

Company information

Official name
Pharma Equity Group A/S
Personnel
1 person
Established
2002
Company form
Limited company
Industry
  • Expand more icon64Financial service activities, except insurance and pension funding

Data sources and methodology

The information about Pharma Equity Group A/S combines official Danish company and financial-statement data with indicators calculated by Valuatum Oy.

Company information

Name, CVR number, address, industry and legal form are based on the Danish Central Business Register (CVR).

CVR / Virk

Annual accounts

Financial figures come from annual reports published through the Danish Business Authority. The latest financial year used is 2016.

Key figures and credit risk

Valuatum Oy calculates financial ratios, comparisons and credit-risk indicators from the available accounts. The results support analysis and do not constitute a standalone credit decision.

Valuatum Oy

About Pharma Equity Group A/S

Pharma Equity Group A/S (CVR number: 2679141-3) is a company from HØRSHOLM. The company recorded a gross profit of 0 kDKK in 2016. The operating profit was -1320 kDKK, while net earnings were 2660 kDKK. The profitability of the company measured by Return on Assets (ROA) was 4.1 %, which can be considered decent but Return on Equity (ROE) was 3.6 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 89 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Pharma Equity Group A/S's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.

Financial information

See financials

Gross profit (kDKK)

EBIT (kDKK)

Profitability

Solidity

Key figures (kDKK)

See financials
2013
2014
2015
2016
Volume
Net sales
Gross profit
EBIT-5 239.00-2 003.00-2 710.00-1 320.00
Net earnings- 155 340.00-5 930.00938.002 660.00
Shareholders equity total- 105 440.0071 634.0072 572.0074 491.00
Balance sheet total (assets)75 450.0074 719.0080 635.0083 743.00
Net debt- 376.00556.00
Profitability
EBIT-%
ROA-1.4 %1.7 %4.1 %
ROE-8.1 %1.3 %3.6 %
ROI-5.0 %1.9 %4.6 %
Economic value added (EVA)-5 471.623 181.80-6 310.36-4 966.74
Solvency
Equity ratio95.9 %90.0 %89.0 %
Gearing0.0 %
Relative net indebtedness %
Liquidity
Quick ratio0.10.71.0
Current ratio0.10.71.0
Cash and cash equivalents349.002.00376.00- 556.00
Capital use efficiency
Trade debtors turnover (days)
Net working capital %

Variable visualization

ROA FY 2016
4.07%
Rating 40/100
-20%
0%
4%
11%
24%
60%
Graph showing the distribution of the variable
Equity ratio FY 2016
89.0%
Rating 69/100
-1%
21%
50%
81%
99%
100%
Graph showing the distribution of the variable

Credit Risk Report

Affordable credit risk report
for basic company risk checks.

Check the creditworthiness of Pharma Equity Group A/S before offering payment terms. The report combines financial figures, risk scores, credit rating, bankruptcy risk and a credit-limit recommendation in one PDF.

AI Credit Risk Report

The core credit-risk figures,
explained with AI.

The AI Credit Risk Report contains the same core financial figures and risk measures as the Credit Risk Report. It also provides written analysis of the company's finances, risks, repayment capacity and assets, together with relevant context from web searches.

  1. 01 Includes the same financial figures, risk scores, credit rating and bankruptcy risk as the Credit Risk Report.
  2. 02 AI complements the analysis with web searches and brings in the relevant company and operating-environment observations.
  3. 03 The written analysis is more precise, more readable and better suited to decision-making.
… / report

Company-specific, AI-assisted credit risk report in PDF format.

For larger customers

Reports can be tailored to your own credit process: content structure, peer groups, risk thresholds, delivery method and AI-analysis weightings can all be adapted to your needs.
Ask about a tailored solution: contact@creditreports.dk

The report is intended for an initial financial assessment. · The final credit decision and any further verification are always the user's responsibility. · One-time payment, no subscription.

What the report includes

8 sections
Financial figures
Risk scores
Credit rating
Bankruptcy risk
AI web-search highlights
Written risk analysis
Conclusions
Ratio appendices

Roles

Companies in the same industry

Page generated